Elevate Capital Advisors, LLC Roivant Sciences Ltd. Transaction History
Elevate Capital Advisors, LLC
- $108 Billion
- Q1 2025
A detailed history of Elevate Capital Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Elevate Capital Advisors, LLC holds 177,394 shares of ROIV stock, worth $2.05 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
177,394
Previous 178,853
0.82%
Holding current value
$2.05 Million
Previous $2.12 Billion
15.4%
% of portfolio
1.66%
Previous 1.86%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$759 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$714 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$531 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$470 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$415 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.13B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...